Related Experiment Videos
Immunisation against panleukopenia: early development of immunity
A Brun1, G Chappuis, P Précausta
1IFFA-Mérieux, Lyon, France.
Comparative Immunology, Microbiology and Infectious Diseases
|January 1, 1979
Summary
This study shows a modified live vaccine provides cats with early immunity against Panleukopenia within 72 hours. Vaccinated kittens can safely enter contaminated areas immediately after inoculation.
Area of Science:
- Veterinary Immunology
- Virology
- Feline Infectious Diseases
Background:
- Feline Panleukopenia (FPV) is a highly contagious and often fatal viral disease in cats.
- Rapid and effective immunization is crucial for protecting vulnerable feline populations.
- Existing vaccines may have varying onset times for protective immunity.
Purpose of the Study:
- To determine the speed of immunity development following vaccination with a modified live Panleukopenia vaccine.
- To assess the safety and efficacy of the vaccine in protecting kittens exposed to a contaminated environment shortly after inoculation.
Main Methods:
- Administration of a modified live Panleukopenia vaccine via subcutaneous route in cats.
- Monitoring of immune response and time to full immunity post-vaccination.
- Challenge studies involving exposure of vaccinated kittens to a Panleukopenia virus-contaminated environment.
Main Results:
- Full immunity against Feline Panleukopenia was achieved within 72 hours post-vaccination.
- Kittens vaccinated with the modified live vaccine demonstrated protection when immediately introduced to a contaminated environment.
- No clinical signs of Panleukopenia were observed in vaccinated kittens following exposure.
Conclusions:
- The modified live vaccine offers a rapid onset of immunity against Feline Panleukopenia.
- Early post-vaccinal protection allows for immediate safe exposure of kittens to environments with Feline Panleukopenia virus risk.
- This vaccine provides a valuable tool for timely disease prevention in feline populations.